Literature DB >> 2433883

Plasma factor XIII and some other haemostasis parameters in patients with diabetic angiopathy.

J Kłoczko, M Wojtukiewicz, M Bielawiec, B Zarzycka, I Kinalska.   

Abstract

Since intravascular and endoparietal fibrin deposition is thought to be involved in the development of atherosclerosis, we measured factor XIII activity and its subunit 'a' and 'b' concentrations against a background of other haemostasis parameters in diabetics with angiopathy and in 2 control groups (healthy subjects and diabetics without vascular complications). Diabetics with angiopathy revealed a significant increase of factor XIII activity as well as its subunit concentrations. They also had significantly elevated anti-thrombin III, alpha 2 macroglobulin, alpha 1 antitrypsin, C1 inhibitor, fibrinogen, FDP concentrations and prolongation of euglobulin lysis time. The highest factor XIII levels were found in diabetics with renal failure. We suppose that increased factor XIII level and other observed changes of haemostasis in patients with diabetic angiopathy might promote intravascular and endoparietal fibrin deposition and contribute to the development of atherosclerotic complications of diabetes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2433883     DOI: 10.1159/000206026

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  4 in total

1.  Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII.

Authors:  V C Yee; L C Pedersen; I Le Trong; P D Bishop; R E Stenkamp; D C Teller
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

2.  Polymerisation and crosslinking of fibrin monomers in diabetes mellitus.

Authors:  A Lütjens; T W Jonkhoff-Slok; C Sandkuijl; E A vd Veen; J vd Meer
Journal:  Diabetologia       Date:  1988-11       Impact factor: 10.122

Review 3.  Diabetes and atherothrombosis: The circadian rhythm and role of melatonin in vascular protection.

Authors:  Anastasia Otamas; Peter J Grant; Ramzi A Ajjan
Journal:  Diab Vasc Dis Res       Date:  2020 Mar-Apr       Impact factor: 3.291

4.  Tocilizumab Effects on Coagulation Factor XIII in Patients with Rheumatoid Arthritis.

Authors:  Roberta Gualtierotti; Francesca Ingegnoli; Massimo Boscolo; Samantha Griffini; Elena Grovetti; Massimo Cugno
Journal:  Adv Ther       Date:  2019-10-25       Impact factor: 3.845

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.